Cellectis (CLLS) EPS (Basic): 2015-2023
Historic EPS (Basic) for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$0.31.
- Cellectis' EPS (Basic) rose 50.79% to -$0.31 in Q3 2023 from the same period last year, while for Sep 2023 it was -$1.68, marking a year-over-year decrease of 15.07%. This contributed to the annual value of -$2.33 for FY2022, which is 8.63% up from last year.
- Per Cellectis' latest filing, its EPS (Basic) stood at -$0.31 for Q3 2023, which was down 55.00% from -$0.20 recorded in Q2 2023.
- Cellectis' EPS (Basic)'s 5-year high stood at $0.47 during Q1 2020, with a 5-year trough of -$0.95 in Q4 2020.
- For the 3-year period, Cellectis' EPS (Basic) averaged around -$0.42, with its median value being -$0.55 (2021).
- Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 364.71% in 2019, then spiked by 244.83% in 2022.
- Quarterly analysis of 5 years shows Cellectis' EPS (Basic) stood at -$0.88 in 2019, then declined by 7.95% to -$0.95 in 2020, then soared by 42.11% to -$0.55 in 2021, then fell by 7.27% to -$0.59 in 2022, then skyrocketed by 50.79% to -$0.31 in 2023.
- Its last three reported values are -$0.31 in Q3 2023, -$0.20 for Q2 2023, and -$0.58 during Q1 2023.